Mesirow Financial Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26M Buy
14,518
+120
+0.8% +$41.1K 0.08% 141
2026
Q1
$5.07M Buy
14,398
+1,261
+10% +$450K 0.08% 142
2025
Q4
$4.3M Sell
13,137
-1,901
-13% -$603K 0.09% 141
2025
Q3
$4.24M Sell
15,038
-40
-0.3% -$11.6K 0.08% 146
2025
Q2
$4.21M Buy
15,078
+864
+6% +$245K 0.08% 140
2025
Q1
$4.43M Buy
14,214
+127
+0.9% +$37.5K 0.09% 139
2024
Q4
$3.67M Buy
14,087
+205
+1% +$60.8K 0.07% 151
2024
Q3
$4.47M Buy
13,882
+106
+0.8% +$34.7K 0.09% 136
2024
Q2
$4.31M Sell
13,776
-117
-0.8% -$34.4K 0.1% 136
2024
Q1
$3.95M Buy
13,893
+1,077
+8% +$315K 0.09% 137
2023
Q4
$3.69M Buy
+12,816
New +$3.49M 0.13% 105

Other funds holding AMGN

Mesirow Financial Investment Management's AMGN Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its Amgen (AMGN) stake by 0.83% in Q2 2026, buying an estimated $41.1K and bringing the position to 14,518 shares worth $5.26M. The position accounts for 0.08% of the portfolio, ranked #141.

Mesirow Financial Investment Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mesirow Financial Investment Management held 14,518 shares of Amgen worth $5.26M as of Q2 2026.
  • Mesirow Financial Investment Management bought 120 Amgen shares in Q2 2026, an estimated $41.1K.
  • Amgen made up 0.08% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #141 holding.
  • Mesirow Financial Investment Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.